Immunic Hosts Progressive Multiple Sclerosis R&D Day

Bitget2026/10/29 10:30

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Immunic will host a virtual progressive multiple sclerosis R&D Day on November 5, 2026, at 12:30 p.m. ET.
Discussions will focus on vidofludimus calcium’s potential in progressive MS, including plans to initiate a Phase 3 trial later in 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immunic Inc. published the original content used to generate this news brief via EQS News (Ref. ID: corporate_2424564_en) on October 29, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Immunic Hosts Progressive Multiple Sclerosis R&D Day

You may also like

Crypto prices